NIRVANA-1: Maintenance therapy with niraparib versus niraparib –bevacizumab in patients with advanced ovarian cancer - supplementary material

dataset

posted on 2023-08-31, 13:37 authored by Syrine Sghaier, Pauline Corbaux, Isabelle Ray-Coquard, Myong Cheol Lim, Kosei Hasegawa, Els Van Nieuwenhuysen, Antonio Gonzalez, Francesco Raspagliesi, Gilles Freyer

Criteria for discontinuing allocated interventions for participant and dose modifications